Skip to content
GenoLensGenoLens

CXCL8

Chr 4q13.3

C-X-C motif chemokine ligand 8

Aliases:
SCYB8, LUCT, LECT, MDNCF, TSG-1
MANE:
ENST00000307407.8

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • COVID-19 research

    Unknown
  • Familial Meniere Disease

  • Pancreatitis

Disease associations (Open Targets)

  • coronary artery disorder

    0.35
  • myocardial infarction

    0.35
  • ischemic stroke

    0.34
  • placenta praevia

    0.21
  • endocrine system disorder

    0.19
  • hepatocellular carcinoma

    0.14
  • melanoma

    0.14
  • contact dermatitis

    0.14
  • chronic obstructive pulmonary disease

    0.14
  • non-small cell lung carcinoma

    0.13

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Interleukin-8

Chemotactic factor that mediates inflammatory response by attracting neutrophils, basophils, and T-cells to clear pathogens and protect the host from infection (PubMed:18692776, PubMed:7636208). Also plays an important role in neutrophil activation (PubMed:2145175, PubMed:9623510). Released in response to an inflammatory stimulus, exerts its effect by binding to the G protein-coupled receptors CXCR1 and CXCR2, primarily found in neutrophils, monocytes and endothelial cells (PubMed:1840701, PubMed:1891716). G protein heterotrimer (alpha, beta, gamma subunits) constitutively binds to CXCR1/CXCR2 receptor and activation by IL8 leads to beta and gamma subunits release from Galpha (GNAI2 in neutrophils) and activation of several downstream signaling pathways including PI3K and MAPK pathways (PubMed:11971003, PubMed:8662698)

Curated MONDO disease pages that list CXCL8 among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.